Repligen | RGEN - Market Capitalization


Repligen reported $9.59B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.13B 191M Jun/2026
General Electric Aerospace USD 389.93B 93.44B Jun/2026
Henry Schein USD 9.68B 1.4B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Repligen USD 7.7B 1.05B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Waters USD 37.24B 7.38B Jun/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026